Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2009. Start Trial.
Date Value
September 30, 2026 100.0%
August 31, 2026 100.0%
July 31, 2026 100.0%
June 30, 2026 100.0%
May 31, 2026 100.0%
April 30, 2026 100.0%
March 31, 2026 100.0%
February 28, 2026 100.0%
January 31, 2026 100.0%
December 31, 2025 91.47%
November 30, 2025 91.47%
October 31, 2025 91.47%
September 30, 2025 91.47%
August 31, 2025 91.47%
July 31, 2025 91.47%
June 30, 2025 91.47%
May 31, 2025 91.47%
April 30, 2025 91.47%
March 31, 2025 91.47%
February 28, 2025 91.47%
January 31, 2025 91.47%
December 31, 2024 91.47%
November 30, 2024 91.47%
October 31, 2024 91.47%
September 30, 2024 91.47%
Date Value
August 31, 2024 91.47%
July 31, 2024 91.47%
June 30, 2024 91.47%
May 31, 2024 91.47%
April 30, 2024 91.47%
March 31, 2024 91.47%
February 29, 2024 91.47%
January 31, 2024 91.47%
December 31, 2023 91.47%
November 30, 2023 91.47%
October 31, 2023 91.47%
September 30, 2023 91.47%
August 31, 2023 91.47%
July 31, 2023 91.47%
June 30, 2023 91.47%
May 31, 2023 91.47%
April 30, 2023 91.47%
March 31, 2023 91.47%
February 28, 2023 91.47%
January 31, 2023 91.47%
December 31, 2022 91.47%
November 30, 2022 91.47%
October 31, 2022 91.47%
September 30, 2022 91.47%
August 31, 2022 91.47%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Lumos Diagnostics Holdings Ltd. 99.18%
Immutep Ltd. 95.17%
Vivos, Inc. 96.09%
CSL Ltd. 69.95%
Ceryvyn Therapeutics Ltd. 99.95%